Hologic Ebitda from 2010 to 2024

HOLX Stock  USD 78.97  0.25  0.32%   
Hologic EBITDA yearly trend continues to be fairly stable with very little volatility. EBITDA is likely to outpace its year average in 2024. During the period from 2010 to 2024, Hologic EBITDA regression line of annual values had r-squared of  0.49 and arithmetic mean of  1,066,524,200. View All Fundamentals
 
EBITDA  
First Reported
1988-12-31
Previous Quarter
344.9 M
Current Value
328.1 M
Quarterly Volatility
178.7 M
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 324.4 M, Interest Expense of 74.8 M or Total Revenue of 4.2 B, as well as many indicators such as Price To Sales Ratio of 5.0, Dividend Yield of 0.0 or PTB Ratio of 3.56. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
  
Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Latest Hologic's Ebitda Growth Pattern

Below is the plot of the Ebitda of Hologic over the last few years. It is Hologic's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hologic's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

Hologic Ebitda Regression Statistics

Arithmetic Mean1,066,524,200
Geometric Mean634,475,855
Coefficient Of Variation68.25
Mean Deviation514,368,640
Median1,002,200,000
Standard Deviation727,937,551
Sample Variance529893.1T
Range2.9B
R-Value0.70
Mean Square Error292568.6T
R-Squared0.49
Significance0
Slope113,627,079
Total Sum of Squares7418503.1T

Hologic Ebitda History

20241.4 B
20231.3 B
20221.1 B
20212.1 B
20202.9 B
20191.5 B
2018597.5 M

About Hologic Financial Statements

Hologic investors use historical fundamental indicators, such as Hologic's Ebitda, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EBITDA1.3 B1.4 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.